What Uromedtech does

UroMedTech Pte. Ltd. is a Singapore-based privately held medical technology company founded to develop urological diagnostic and procedural devices. Its core product is the UroMaster Adventure, a robot-guided MRI-ultrasound fusion biopsy system for precision transperineal prostate biopsy, comprising three integrated components: the Uro-Matic ultrasound workstation, the AccuBot transperineal robotic assistance system, and the UroPro MRI-ultrasound fusion software. The system uses AI-powered One-Click Auto-Segmentation and Auto-Registration functions and sub-millimeter robotic needle positioning with an adjustable insertion angle of plus or minus 30 degrees to reduce false negative biopsies and eliminate sepsis risk associated with transrectal approaches.

The company operates a hardware-led revenue model, selling capital equipment directly to hospital urology departments through enterprise field sales supplemented by live demonstration cases and on-site training. Its portfolio also includes the BVS-Pro wireless portable 3D ultrasound bladder scanner (with EHR/EPD integration via DICOM and HL7) and the S-MM-2.3 Multi Modality Prostate Phantom for clinical training, both distributed under exclusive regional agreements. Marketing is concentrated on a corporate website, LinkedIn presence, scientific publication citations, and press announcements.

As of January 2025, UroMedTech's commercial footprint is limited to Singapore and Malaysia, with the IUN at General Hospital Kuala Lumpur serving as its flagship regional reference site. The company is founder/management-owned with no disclosed institutional funding, external investors, or regulatory clearances (e.g., FDA 510(k), CE Mark) referenced in available sources.

Name

Uromedtech

Legal name

UroMedTech Pte. Ltd.

Website

https://uromedtech.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

UroMedTech Pte. Ltd. is a Singapore-based privately held medical technology company that develops and sells the UroMaster Adventure robot-guided MRI-ultrasound fusion biopsy system, BVS-Pro bladder scanner, and prostate training phantoms to hospital urology departments in Singapore and Malaysia.

Ownership category

akta.pro rank

Product category

Urology Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Urologic Oncology (HLAKAOAB)

Keywords

• MRI-US fusion biopsy
• Prostate cancer diagnostics
• Urology medical devices
• Robot-guided biopsy
• Bladder volume scanning

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Hardware Sales: Sale of urological medical devices including the UroMaster Adventure MRI-US Fusion Biopsy System, BVS-Pro Ultrasound Bladder Scanner, and Prostate Phantom training models to hospitals and healthcare institutions

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

UroMedTech develops and sells urological medical devices, primarily the UroMaster Adventure robot-guided MRI-US Fusion Biopsy System for precision transperineal prostate biopsy. The company also distributes the BVS-Pro wireless 3D ultrasound bladder volume scanner and the S-MM-2.3 multi-modality prostate phantom for medical training. All products are targeted at hospitals, urology departments, and medical training institutions for improved diagnostic accuracy in prostate cancer detection and urological care.

Product overview

Uromedtech offers a portfolio of urological medical devices centered on the UroMaster Adventure system, an MRI-US Fusion Prostate Biopsy System. The UroMaster Adventure consists of three integrated components: the Uro-Matic Ultrasound Workstation, the AccuBot Transperineal Robotic Assistance System, and the UroPro MRI-Ultrasound Fusion Software. Additionally, the company distributes the BVS-Pro, a wireless 3D ultrasound bladder volume scanner, and the S-MM-2.3 Multi Modality Prostate Phantom Model for medical training. These products address prostate cancer diagnostics, bladder assessment, and medical procedure training.

Differentiator

Problem solved

Functional benefit

Brands

• UroMaster Adventure: Robot-guided MRI-US Fusion Biopsy System for prostate cancer diagnostics with AI-powered auto-segmentation and auto-registration functions.
• BVS-Pro
• S-MM-2.3 Prostate Phantom
• Uro-Matic Ultrasound Workstation
• AccuBot Transperineal Robotic Assistance System
• UroPro MRI-Ultrasound Fusion Software

Products and services

• UroMaster Adventure A robot-guided MRI-US Fusion Biopsy System designed for precision transperineal prostate biopsy, combining real-time ultrasound imaging with MRI fusion and robotic assistance for accurate tissue sampling. Targeted at hospital urology departments and urologists performing prostate cancer diagnostics.
• BVS-Pro A wireless, portable 3D ultrasound bladder volume scanner with automatic gender selection, rechargeable battery, and smartphone/tablet connectivity. Designed for diagnosis and treatment of urological conditions including bladder volume measurement and urinary retention assessment. Targeted at healthcare professionals and mobile healthcare workers.
• S-MM-2.3 Multi Modality Prostate Phantom Model

Quantifiable outcome

• Significantly upgrades prostate cancer detection compared to systematic 12-core transrectal ultrasound biopsy (based on published clinical studies)
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature7 records

Partnerships

One partnership is on record.

• National Institute of Urology and Nephrology (IUN) at General Hospital Kuala LumpurcoreStrategic or Co-development Partner · 1 January 2025UroMedTech partnered with Malaysia's National Institute of Urology and Nephrology (IUN) at General Hospital Kuala Lumpur for live demonstration cases of the UroMaster Adventure system. The institute is a national centre of urology offering specialized training and equipped with state-of-the-art facilities and advanced operating theatres. The partnership enables UroMedTech to demonstrate its robotic prostate fusion biopsy technology to urology experts in the region.

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Koelis: French developer of MRI/TRUS fusion biopsy systems for prostate cancer, including the Trinity and OASIS platforms. Direct competitor offering image-guided, fusion-based prostate biopsy workflows to urology departments in hospitals globally.
• MedCom: German developer of image registration and fusion software (e.g., BioFusion) used in MRI-US fusion biopsy and other image-guided interventions. Direct software peer competing in the fusion workflow layer that UroMedTech's UroPro software addresses.
• Biobot Surgical: Singapore-based developer of the iSR'obot Mona Lisa, a robotic transperineal prostate biopsy system. Direct peer in robot-guided transperineal biopsy targeting the same hospital urology customer base as UroMaster Adventure, with regional Asian distribution.
• Eigen (GE Healthcare): Developer of the Artemis MRI-US fusion biopsy system, now part of GE Healthcare. Direct competitor in prostate fusion biopsy with FDA-cleared hardware and software used in hospital urology practices worldwide.

Emerging players

• SonaCare Medical: Developer of image-guided high-intensity focused ultrasound (HIFU) systems for prostate tissue ablation. Emerging player with partial overlap in the image-guided urology intervention space that UroMedTech's robotic platform could expand into via adjacent indications.
• MIM Software: Specialist in medical imaging analysis and fusion software used across radiology, oncology, and image-guided interventions. Emerging player with partial overlap to UroMedTech's UroPro fusion software capabilities in prostate biopsy and image-guided therapy.

Broad incumbents

• BK Medical (GE Healthcare): Specialist in urology and interventional ultrasound, now part of GE Healthcare. Provides ultrasound platforms widely used in prostate biopsy and fusion workflows, making it a broad incumbent competing for the same hospital urology capital budget.
• Esaote: Italian manufacturer of diagnostic ultrasound systems, including specialty transducers and platforms used in urology and prostate imaging. Broad incumbent offering overlapping hardware used in fusion and ultrasound-guided prostate biopsy workflows.
• Philips (UroNav): Philips offers UroNav, an MRI-ultrasound fusion platform for targeted prostate biopsy, integrated with its broader imaging and interventional portfolio. Operates as a broad incumbent with global hospital reach and deep KOL networks that compete with UroMedTech's fusion positioning.
• Hitachi / FUJIFILM Healthcare: Offers diagnostic ultrasound and real-time tissue elastography systems used for prostate imaging and biopsy guidance. Operates as a broad incumbent with global installed bases and competes for the same urology capital purchasing slots.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/uromedtech-pte-ltd
• Xx.com/UromedTech

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uromedtech